Company Profile
- Stock Code
- REGN
- ISIN Code
- US75886F1075
- Currency
- US Dollar (USD)
- IPO Date
- 1991-04-02

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injectio...